Alessandro Di Spiezio

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kayvon Pedram, Nouf N Laqtom, D Judy Shon, Alessandro Di Spiezio, Nicholas M Riley, Paul Saftig, Monther Abu-Remaileh, Carolyn R Bertozzi
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals. Proceedings of the National Academy of Sciences of the United States of America 119 (39) (2022)
Susy Prieto Huarcaya, Alice Drobny, André R A Marques, Alessandro Di Spiezio, Jan Philipp Dobert, Denise Balta, Christian Werner, Tania Rizo, Lisa Gallwitz, Simon Bub, Iva Stojkovska, Nandkishore R Belur, Jens Fogh, Joseph R Mazzulli, Wei Xiang, Amitkumar Fulzele, Mario Dejung, Markus Sauer, Beate Winner, Stefan Rose-John, Philipp Arnold, Paul Saftig, Friederike Zunke
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models. Autophagy 18 (5) (2022)
André R A Marques, Alessandro Di Spiezio, Niklas Thießen, Lina Schmidt, Joachim Grötzinger, Renate Lüllmann-Rauch, Markus Damme, Steffen E Storck, Claus U Pietrzik, Jens Fogh, Julia Bär, Marina Mikhaylova, Markus Glatzel, Mahmoud Bassal, Udo Bartsch, Paul Saftig
Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis. Autophagy 16 (5) (2019)

Alessandro Di Spiezio.css-eqlu8i{font-size:small;padding-left:4px;}